Suprascapular Nerve Block in Addition to Intra-articular Corticosteroid Injection in Adhesive Capsulitis
Adhesive Capsulitis of the Shoulder
About this trial
This is an interventional treatment trial for Adhesive Capsulitis of the Shoulder focused on measuring Adhesive Capsulitis of the Shoulder, Intra-Articular Injections, Nerve Blockade
Eligibility Criteria
Inclusion criteria:
- Diagnosis of adhesive capsulitis
- Bening of symptoms at least three months prior
- Having shoulder pain with passive ROM limitation greater than 30° compared to normal values in at least two directions
Exclusion criteria were:
- Adhesive capsulitis stages 3 and 4
- Previous trauma, IAI, or surgery history
- Evidence of complete rotator cuff tear, calcific tendinitis, biceps tendinitis, glenohumeral or acromioclavicular arthritis on magnetic resonance imaging
- Uncontrolled diabetes mellitus
- Known coagulation disorder
- Contraindication to corticosteroid or local anesthetic injection.
Sites / Locations
- Kardelen Gencer Atalay
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
The IAI and SSNB group
The only-IAI group
Ultrasound-guided IAI and SSNB are planned to apply by at least three-year experienced physiatrists. Patients are planned to initiate a six-week rehabilitation program supervised by the same physiotherapist one day after the intervention.
Ultrasound-guided IAI is planned to apply by at least three-year experienced physiatrists. Patients are planned to initiate a six-week rehabilitation program supervised by the same physiotherapist one day after the intervention.